Responses
Rheumatoid arthritis
Original article
Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study
Compose a Response to This Article
Other responses
No responses have been published for this article.